Genoskin appoints DR Nicolas Gaudenzio as chief scientific officer
World-renowned expert in immunology and allergic skin inflammation, Dr Nicolas Gaudenzio has just been appointed as CSO of ex vivo clinical testing specialist Genoskin. He also leads a research group at Inserm – the French National Institute of Health and Medical Research – in the field of skin neuro-immunology, inflammation and imaging
His expertise in skin immunology and imaging of the human immune system will guide Genoskin’s strategic shift towards immunology expert services for the pharmaceutical industry
Banook group acquires german counterpart Nabios gmbh to become a European leader in cardiac safety services
First external acquisition allows Banook Group to strengthen its presence in Central and Eastern Europe
Hephaï receives 2021 Catalyst Award from US National Academy of Medicine for its unique digital education platform
CARTHERA’S SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
Low Intensity Pulsed Ultrasound device can enhance delivery of CAR-T therapies and penetration of checkpoint inhibitors into the brain of preclinical glioma models; increasing probability of long-lasting immunity
Robocath and Rennes University Hospital launch co-development research program into treatment of strokes in partnership with Philips France
Electroducer announces major medical advance in treatment of heart valve disease; raises €3 million to market its device in Europe and US – commencing in 2022
Hephaï files software patent for its digital education platform designed to improve patient inhaler use
CarThera’s SonoCloud technology enhances the efficacy of immunotherapies for the treatment of brain tumors
